Suchergebnisse - "Peel, Michael"

PubPharm (44)

1

Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs) : A Modular Platform for Generating Reversible, Self-Assembling Bifunctional Targeted Degraders

enthalten in: Journal of medicinal chemistry | 2024

von Giardina, S. | Valdambrini, E. | Singh, P. | +5

2

Breeding Efficiency for Salt Tolerance in Alfalfa

enthalten in: Life (Basel, Switzerland) | 2023

von Peel, M. | Anower, M. | Wu, Y.

3

Fear of the human "super predator" pervades the South African savanna

enthalten in: Current biology : CB | 2023

von Zanette, L. | Frizzelle, N. | Clinchy, M. | +4

CommentIn: Curr Biol. 2023 Nov 6;33(21):R1158-R1160. - PMID 37935131

4

Dry matter intake and feed efficiency of heifers from 4 dairy breed types grazing organic grass and grass-birdsfoot trefoil mixed pastures

enthalten in: Journal of dairy science | 2023

von Greenland, M. | Waldron, B. | Isom, S. | +8

5

The effects of organic grass and grass-birdsfoot trefoil pastures on Jersey heifer development : Herbage characteristics affecting intake

enthalten in: Journal of dairy science | 2021

von Rose, M. | Waldron, B. | Isom, S. | +8

6

The effects of organic grass and grass-birdsfoot trefoil pastures on Jersey heifer development : Heifer growth, performance, and economic impact

enthalten in: Journal of dairy science | 2021

von Hadfield, J. | Waldron, B. | Isom, S. | +12

7

Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models

enthalten in: Immunotherapy | 2021

von Huarte, E. | Peel, M. | Juvekar, A. | +8

8

Multi-omic profiling of pituitary thyrotropic cells and progenitors

enthalten in: BMC biology | 2021

von Daly, A. | Dudley, L. | Peel, M. | +3

9

Baryon Acoustic Oscillations from Integrated Neutral Gas Observations : an instrument to observe the 21cm hydrogen line in the redshift range 0.13 < z < 0.45 - status update

enthalten in: Anais da Academia Brasileira de Ciencias | 2021

von Wuensche, C. | Abdalla, E. | Abdalla, F. | +48

10

Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome

enthalten in: Frontiers in pharmacology | 2021

von Huarte, E. | Peel, M. | Verbist, K. | +5

1
2
3
4
5
Nächster »
[5]